Garred Peter
Department of Clinical Immunology, Section 7631, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Biochem Soc Trans. 2008 Dec;36(Pt 6):1461-6. doi: 10.1042/BST0361461.
MBL (mannose-binding lectin) is primarily a liver-derived collagen-like serum protein. It binds sugar structures on micro-organisms and on dying host cells and is one of the four known mediators that initiate activation of the complement system via the lectin pathway. Common variant alleles situated both in promoter and structural regions of the human MBL gene (MBL2) influence the stability and the serum concentration of the protein. Epidemiological studies have suggested that genetically determined variations in MBL serum concentrations influence the susceptibility to and the course of different types of infectious, autoimmune, neoplastic, metabolic and cardiovascular diseases, but this is still a subject under discussion. The fact that these genetic variations are very frequent, indicates a dual role of MBL. This overview summarizes the current molecular understanding of human MBL2 genetics.
甘露糖结合凝集素(MBL)主要是一种源自肝脏的胶原样血清蛋白。它能结合微生物及濒死宿主细胞上的糖结构,是已知的通过凝集素途径启动补体系统激活的四种介质之一。位于人类MBL基因(MBL2)启动子和结构区域的常见变异等位基因会影响该蛋白的稳定性和血清浓度。流行病学研究表明,MBL血清浓度的基因决定变异会影响对不同类型感染性、自身免疫性、肿瘤性、代谢性和心血管疾病的易感性及病程,但这仍是一个有待探讨的问题。这些基因变异非常常见,这一事实表明MBL具有双重作用。本综述总结了目前对人类MBL2遗传学的分子认识。